9,10-dihydroergosine
- CAS No.
- 7288-61-1
- Chemical Name:
- 9,10-dihydroergosine
- Synonyms
- Dihydroergosine;9,10-dihydroergosine;Dihydro Ergotamine Impurity 3;9,10α-Dihydro-12'-hydroxy-2'-methyl-5'α-(2-methylpropyl)ergotaman-3',6',8'-trione;Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(2-methylpropyl)-, (5'α,10α)-;(6aR,9R,10aR)-N-[(2R,5S,10aS,10bS)-10b-hydroxy-2-methyl-5-(1-methylethyl)-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide (dihydroergosine),;(6aR,9R,10aR)-N-[(2S,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-(1-methylethyl)-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide(2′-epidihydroergocristine),
- CBNumber:
- CB71318989
- Molecular Formula:
- C30H39N5O5
- Molecular Weight:
- 549.67
- MDL Number:
- MOL File:
- 7288-61-1.mol
Last updated:2023-05-04 15:13:17
| Melting point | 212 °C (decomp) |
|---|---|
| Boiling point | 846.9±65.0 °C(Predicted) |
| Density | 1.40±0.1 g/cm3(Predicted) |
| pka | 9.65±0.60(Predicted) |
| FDA UNII | 5V68W0Y9VC |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS07,GHS08 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H362-H332-H361-H312 |
| Precautionary statements | P201-P260-P263-P264-P270-P308+P313-P201-P202-P281-P308+P313-P405-P501-P280-P302+P352-P312-P322-P363-P501-P264-P270-P301+P312-P330-P501-P261-P271-P304+P340-P312 |
9,10-dihydroergosine Preparation Products And Raw materials
Raw materials
Preparation Products
9,10-dihydroergosine Suppliers
Global( 3)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Zhuhai Anzhe Biotechnology Co,Ltd. | 13570603050 | 793448631@qq.com | China | 3015 | 58 |
| Supplier | Advantage |
|---|---|
| Zhuhai Anzhe Biotechnology Co,Ltd. | 58 |
9,10-dihydroergosine
9,10α-Dihydro-12'-hydroxy-2'-methyl-5'α-(2-methylpropyl)ergotaman-3',6',8'-trione
Dihydroergosine
Dihydro Ergotamine Impurity 3
Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(2-methylpropyl)-, (5'α,10α)-
(6aR,9R,10aR)-N-[(2R,5S,10aS,10bS)-10b-hydroxy-2-methyl-5-(1-methylethyl)-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide (dihydroergosine),
(6aR,9R,10aR)-N-[(2S,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-(1-methylethyl)-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide(2′-epidihydroergocristine),
7288-61-1